Literature DB >> 20640848

Autologous platelet gel in total knee arthroplasty: a prospective randomized study.

Wieger G Horstmann1, Robert Slappendel, Gijs G van Hellemondt, Ate W Wymenga, Nigel Jack, Peter A M Everts.   

Abstract

PURPOSE: Total knee arthroplasty (TKA) is often associated with major postoperative blood loss, postoperative pain, and impaired wound healing. The application of autologous platelet gel (APG), prepared from the buffy coat of a unit of autologous blood, has been advocated to improve haemostasis after surgery, to decrease perioperative blood loss, diminish postoperative pain and to enhance the wound healing process. This randomized controlled pilot study was developed to assess the effects of APG after total knee arthroplasty on blood loss, wound healing, pain, range of motion, and hospital stay.
METHOD: A prospective, randomized observer blind controlled trial was performed. Forty patients with only osteoarthritis of the knee were scheduled to have a TKA, and they were randomized into two groups. Patients in the treatment group were all treated with the application of autologous platelet gel after the prosthesis was implanted. Patients in the control group were treated with the same protocol but no APG was used.
RESULTS: Preoperative and postoperative Hb levels showed no significant difference and allogenic blood transfusions were not given in either group. Haematomas were significantly larger in the control group than in the platelet gel group (P = 0.03). The pain score at rest was higher in the control group on the 3rd day (P = 0.04). Wound healing disturbances were seen in four patients in the control group and in no patients in the APG group (n.s.). Range of motion of the knee was similar postoperatively. Hospital stay was 6.2 days in the APG and 7.5 days in the control group (n.s.).
CONCLUSION: In this prospective randomized pilot study on APG in total knee arthroplasty, differences in favour of the use of platelet gel were found, but these were subjective evaluations, marginal in effect, or did not reach statistical significance. The use of drains might have decreased the concentration of delivered platelets and may have diminished the effect. However, in this study, a statistically significant clinically important effect in favour of platelet gel application was not found. Further studies with larger numbers of patients, and without the use of drains, are warranted to investigate the possible benefits of autologous platelet gel in total knee arthroplasty.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640848     DOI: 10.1007/s00167-010-1207-0

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  45 in total

1.  Efficacy of concentrated autologous platelet-derived growth factors in chronic lower-extremity wounds.

Authors:  Jody Peter McAleer; Eric Kaplan; Gianni Persich
Journal:  J Am Podiatr Med Assoc       Date:  2006 Nov-Dec

Review 2.  Wound problems in total knee arthroplasty.

Authors:  Kelly G Vince; Ayesha Abdeen
Journal:  Clin Orthop Relat Res       Date:  2006-11       Impact factor: 4.176

3.  Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis.

Authors:  Peter A M Everts; Roger J J Devilee; Cornelis J M Oosterbos; Christine Brown Mahoney; Maarten Eeftinck Schattenkerk; Johannes T A Knape; André van Zundert
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-02-24       Impact factor: 4.342

Review 4.  The use of autologous platelet-leukocyte gels to enhance the healing process in surgery, a review.

Authors:  P A Everts; E P Overdevest; J J Jakimowicz; C J Oosterbos; J P Schönberger; J T Knape; A van Zundert
Journal:  Surg Endosc       Date:  2007-04-13       Impact factor: 4.584

5.  Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus.

Authors:  Dirk Jan F Moojen; Peter A M Everts; Rose-Minke Schure; Ed P Overdevest; André van Zundert; Johannes T A Knape; René M Castelein; Laura B Creemers; Wouter J A Dhert
Journal:  J Orthop Res       Date:  2008-03       Impact factor: 3.494

Review 6.  Allogeneic transfusion and infection: economic and clinical implications.

Authors:  N Blumberg
Journal:  Semin Hematol       Date:  1997-07       Impact factor: 3.851

Review 7.  The wound healing process.

Authors:  R S Kirsner; W H Eaglstein
Journal:  Dermatol Clin       Date:  1993-10       Impact factor: 3.478

8.  Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study.

Authors:  P A Everts; R J J Devilee; C Brown Mahoney; A van Erp; C J M Oosterbos; M Stellenboom; J T A Knape; A van Zundert
Journal:  Eur Surg Res       Date:  2007-11-12       Impact factor: 1.745

9.  Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion.

Authors:  T Bielecki; T S Gazdzik; T Szczepanski
Journal:  Eur Surg Res       Date:  2008-02-15       Impact factor: 1.745

10.  Use of platelet gel and its effects on infection in cardiac surgery.

Authors:  Cody C Trowbridge; Alfred H Stammers; Edward Woods; Bianca R Yen; Myra Klayman; Christian Gilbert
Journal:  J Extra Corpor Technol       Date:  2005-12
View more
  17 in total

1.  Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled study.

Authors:  Aditya K Aggarwal; V S Shashikanth; Neelam Marwaha
Journal:  Int Orthop       Date:  2013-10-11       Impact factor: 3.075

2.  The effect of knee position on blood loss and range of motion following total knee arthroplasty.

Authors:  Bin Li; Yu Wen; Da Liu; Lijie Tian
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-08-03       Impact factor: 4.342

3.  Length of hospital stay with patient-dependent determination in bilateral scheduled staged total knee arthroplasty.

Authors:  Yoshinori Ishii; Hideo Noguchi; Mitsuhiro Takeda; Junko Sato; Tatsuya Suzuki
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-06-27

Review 4.  Considerations for the use of platelet-rich plasma in orthopedics.

Authors:  Taralyn M McCarrel; Nathan A Mall; Andrew S Lee; Brian J Cole; Davietta C Butty; Lisa A Fortier
Journal:  Sports Med       Date:  2014-08       Impact factor: 11.136

5.  Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA.

Authors:  Timothy M Diiorio; Justin D Burkholder; Robert P Good; Javad Parvizi; Peter F Sharkey
Journal:  Clin Orthop Relat Res       Date:  2012-01       Impact factor: 4.176

6.  Knee flexion after total knee arthroplasty reduces blood loss.

Authors:  Alfredo Schiavone Panni; Simone Cerciello; Michele Vasso; Chiara Del Regno
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-10       Impact factor: 4.342

7.  Platelet-rich plasma for the reduction of blood loss after total knee arthroplasty: a clinical trial.

Authors:  Takeshi Mochizuki; Koichiro Yano; Katsunori Ikari; Ryo Hiroshima; Kosei Kawakami; Naoko Koenuma; Mina Ishibashi; Toshikatsu Shirahata; Shigeki Momohara
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-07-22

8.  Impact of Platelet-Rich Plasma Use on Pain in Orthopaedic Surgery: A Systematic Review and Meta-analysis.

Authors:  Herman Johal; Moin Khan; Shu-Hang Patrick Yung; Mandeep S Dhillon; Freddie H Fu; Asheesh Bedi; Mohit Bhandari
Journal:  Sports Health       Date:  2019-05-28       Impact factor: 3.843

9.  The role of platelet rich plasma in musculoskeletal science.

Authors:  Zafar Ahmad; Daniel Howard; Roger A Brooks; John Wardale; Fran Md Henson; Alan Getgood; Neil Rushton
Journal:  JRSM Short Rep       Date:  2012-06-19

10.  Comparative efficacy and safety of topical hemostatic agents in primary total knee arthroplasty: A network meta-analysis of randomized controlled trials.

Authors:  Shaoshuo Li; Baixing Chen; Zhen Hua; Yang Shao; Heng Yin; Jianwei Wang
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.